Vostesyl

N/A

Report date: 2025/01/26 15:58:04
NME

Base Information

Drug NameVostesyl
Drug Alias NameACE-2 modulator (Vossensteyn Biomedical)ACE-2 modulator (Vossensteyn Biomedical)COVID-19 therapeutic (Vossensteyn Biomedical)
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionAngiotensin-converting enzyme 2 modulators
TargetsAngiotensin-converting enzyme 2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Lung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVossensteyn Biomedical
China Registration ClassN/A

Develop Information

Active CompaniesVossensteyn Biomedical
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Lung Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A